AUTL Autolus Therapeutics plc
$1.14
Autolus Therapeutics plc (AUTL) Earnings News
Earnings press releases, previews and reviews for Autolus Therapeutics plc (AUTL), newest first. Our most recent is review: Autolus Beats on Revenue and Lifts Its Aucatzyl Outlook, but a Sequential Sales Dip and a Delayed MS Readout Complicate the Story.
Tuesday
November 10, 2026
10:48 AM ET
Autolus Beats on Revenue and Lifts Its Aucatzyl Outlook, but a Sequential Sales Dip and a Delayed MS Readout Complicate the Story
Earnings Whispers · Review
Tuesday
November 10, 2026
7:00 AM ET
Autolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
Monday
November 2, 2026
11:55 PM ET
Autolus Faces a Credibility Test on Obe-cel Momentum as Shares Slide Below Range Lows
Earnings Whispers · Preview
Monday
October 26, 2026
4:15 PM ET
Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026
Tuesday
August 11, 2026
7:00 AM ET
Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Monday
August 3, 2026
4:05 PM ET
Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
Monday
August 3, 2026
7:13 AM ET
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors